You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ADVAIR

Showing 1 - 25 of 121
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Altitude Edema Trial (Advair HFA, Placebo)

Not yet recruiting
  • Altitude Edema
  • Advair HFA
  • Placebo
  • (no location specified)
Sep 8, 2023

Asthma Trial in Athens (Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals, ADVAIR

Not yet recruiting
  • Asthma
  • Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals
  • +2 more
  • Athens, Greece
    BECRO Ltd.
Jan 20, 2023

Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,

Recruiting
  • Bioequivalence
  • Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
  • ADVAIR DISKUS® 500/50
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Aug 29, 2023

Bioequivalence Trial in Larissa (Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,

Recruiting
  • Bioequivalence
  • Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
  • ADVAIR DISKUS® 250/50
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Aug 1, 2023

Bioequivalence Trial (Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals, ADVAIR DISKUS

Not yet recruiting
  • Bioequivalence
  • Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
  • ADVAIR DISKUS 100/50
  • (no location specified)
Jan 20, 2023

Asthma Trial in Los Angeles (QVAR, Advair, Servent Diskus)

Completed
  • Asthma
  • Los Angeles, California
    UCLA
Nov 19, 2021

Bioequivalence, Asthma Trial in Larissa (Test, Reference)

Active, not recruiting
  • Bioequivalence
  • Asthma
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Oct 19, 2021

Asthma Trial in Raleigh, Edmond, San Antonio (Treatment A: Fp MDPI, Treatment B: FS MDPI, Treatment C Flovent)

Completed
  • Asthma
  • Treatment A: Fp MDPI
  • +3 more
  • Raleigh, North Carolina
  • +2 more
Nov 6, 2021

Asthma Trial in Hackensack, New York (Fluticasone with salmeterol, Fluticasone HFA)

Completed
  • Asthma
  • Fluticasone with salmeterol
  • +3 more
  • Hackensack, New Jersey
  • +2 more
Oct 12, 2022

Asthma, COPD Trial in San Antonio (MGR001, Advair® Diskus®, Seretide™ Accuhaler™)

Completed
  • Asthma
  • COPD
  • San Antonio, Texas
    Worldwide Clinical Trials Early Phase Services
Feb 22, 2022

Asthma Trial in Miami Lakes (Fluticasone Propionate and Salmeterol Inhalation Powder, Placebo Inhalation Powder)

Completed
Has Results
  • Asthma
  • Fluticasone Propionate and Salmeterol Inhalation Powder
  • Placebo Inhalation Powder
  • Miami Lakes, Florida
    Study Site 101
Aug 31, 2021

Asthma Trial in Huntington Beach, Raleigh, San Antonio (Fluticasone Propionate MDPI, Fluticasone Propionate/Salmeterol MDPI,

Completed
  • Asthma
  • Fluticasone Propionate MDPI
  • +2 more
  • Huntington Beach, California
  • +2 more
Nov 5, 2021

Bioequivalence, Asthma Trial in Larissa (Test, Reference)

Active, not recruiting
  • Bioequivalence
  • Asthma
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Apr 18, 2021

Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent, ADVAIR DISKUS®

Completed
  • Bioequivalence
  • Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent
  • ADVAIR DISKUS® 500/50
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Mar 8, 2021

Pooled Analysis FP_SX_250_50

Completed
  • Asthma
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Mar 5, 2021

Bioequivalence Trial in Larissa (Test Product, Reference Product)

Completed
  • Bioequivalence
  • Test Product
  • Reference Product
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Mar 8, 2021

Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent, ADVAIR DISKUS®

Completed
  • Bioequivalence
  • Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent
  • ADVAIR DISKUS® 500/50
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Jan 18, 2021

Bioequivalence Trial in Larissa (Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent, ADVAIR DISKUS®

Completed
  • Bioequivalence
  • Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent
  • ADVAIR DISKUS® 250/50
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Jan 18, 2021

Asthma Trial (Mometasone furoate/formoterol (MF/F) MDI, Fluticasone propionate/salmeterol (F/SC) DPI)

Completed
Has Results
  • Asthma
  • Mometasone furoate/formoterol (MF/F) MDI
  • Fluticasone propionate/salmeterol (F/SC) DPI
  • (no location specified)
Feb 7, 2022

Asthma Trial in Denver (fluticasone propionate and salmeterol, budesonide and formoterol)

Completed
  • Asthma
  • fluticasone propionate and salmeterol
  • budesonide and formoterol
  • Denver, Colorado
    National Jewish Health
Jan 15, 2021

(s)of Airflow Limitation in Moderate-severe Persistent Asthma

Recruiting
  • Asthma
  • Lakewood, California
    Arthur F Gelb Medical Corporation
Feb 5, 2021

Asthma Trial in Athens (Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals, ADVAIR

Completed
  • Asthma
  • Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals
  • +2 more
  • Athens, Greece
    BECRO Ltd.
Jul 5, 2020

COPD, COPD Exacerbation Trial in Winston-Salem (Nebulizers, Dry Powder Inhaler, Brovana)

Terminated
Has Results
  • COPD
  • COPD Exacerbation
  • Nebulizers
  • +6 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Health
Jun 10, 2021

Asthma Trial in United States (MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate), Advair (Fixed

Completed
Has Results
  • Asthma
  • MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate)
  • +2 more
  • Birmingham, Alabama
  • +100 more
Feb 22, 2022

Bronchial Asthma Trial in Orlando (Fluticasone propionate/salmeterol 100/50 µg, Placebo, Advair Diskus 100/50 Dry Powder

Completed
  • Bronchial Asthma
  • Fluticasone propionate/salmeterol 100/50 µg
  • +2 more
  • Orlando, Florida
    Combined Research Orlando
Aug 12, 2020